ArticleFrontiers in immunology2025

Early intrathecal dexamethasone and methotrexate as an effective approach for immune effector cell-associated neurotoxicity syndrome after CAR-T cell therapies.

Juanxia Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.